TrumpRx for GLP-1s: Wegovy and Zepbound costs, and who saves more

TrumpRx is a front door, not a discount. Secondary reports describe it as a government-branded portal that routes you to the manufacturers’ own cash-price programs: NovoCare for Wegovy and LillyDirect for Zepbound. The prices live in those programs. So the useful question isn’t “what does TrumpRx cost?” It’s “which program, and which pricing path, is cheapest for you?”

What we could and could not verify

Treat these numbers as a snapshot. GLP-1 cash prices change often, and some figures are only as current as the pages cited.

We did not retrieve TrumpRx’s own pages. Everything about how the portal works comes from secondary reports, not a primary source.
Several figures came from search snippets, not fully fetched pages.
Lilly’s investor pages returned HTTP 403, so the KwikPen higher-dose prices and the Lilly-government agreement terms are unconfirmed.
NovoCare is not a source we could cite. The Wegovy prices below are unlinked; check them on Novo Nordisk’s site.
Sources conflict on the Wegovy pill 4 mg price ($199 versus $299), on how long the Wegovy pen intro window lasts, and on Medicare Bridge BMI criteria.

Confirm any price before you act on it.

How TrumpRx works in practice

Per those secondary reports, the steps look like this:

Find the drug on the portal.
The portal sends you to the manufacturer’s cash program.
You still need a valid prescription.
The price shown is usually the lowest dose, not what you’ll pay once you titrate up.

That last point matters most. A starter-dose headline says nothing about month four or month ten. Always look up the price for the dose you’ll actually be on.

Zepbound self-pay prices

Lilly’s LillyDirect Zepbound page lists single-dose vial prices through its Self Pay Journey Program, from a December 2025 snapshot:

Dose	Monthly price (program)
2.5 mg	$299
5 mg	$399
7.5 to 15 mg	$449

The refill-timing trap

The $449 price applies only on the first fill, and only if you refill within 45 days of the previous delivery. Outside the program, the same doses run:

7.5 mg: $599
10 mg: $699
12.5 mg: $849
15 mg: $1,049

A late refill can cost you hundreds of dollars a month. On a higher dose, set a reminder well before day 45.

KwikPen pricing

Lilly says the Zepbound KwikPen is sold at self-pay pricing through LillyDirect and major retail pharmacies. The pen holds four weekly doses. It starts at $299 per month for 2.5 mg and $399 per month for 5 mg. A search snippet showed $449 per month for 7.5 mg and 10 mg with a refill within 45 days. We could not fetch the full release, so verify those higher-dose prices.

Wegovy self-pay prices

These figures come from the brief’s notes on Novo Nordisk’s programs, not from a page we could cite. Verify each one.

Wegovy pill

1.5 mg: $149
9 mg and 25 mg: $299
4 mg: unclear. Sources say $199 or $299.

Wegovy pen

$199 per month for new patients at intro doses, then $349.
The higher-dose (HD) pen starts at $399.
The intro windows carry specific end dates. Check the date before you plan around the $199 price.

The pill’s starter doses are the cheapest entry point here. They don’t stay cheap. At 9 mg and 25 mg, the pill costs about what Zepbound’s lower tiers do. For a closer look at the two formats, see our comparison of the Wegovy pill and the injection.

Does the 2027 Novo list price cut lower your cash price?

No. Novo says the January 1, 2027 list price cut to $675 does not change direct-to-patient self-pay prices. It may help people paying toward a deductible or coinsurance, since those costs track list price.

Who saves more elsewhere

Medicare Part D enrollees

The Medicare GLP-1 Bridge is a CMS demonstration running July 1, 2026 through December 31, 2027. Eligible Part D enrollees pay a flat $50 for a one-month supply. Key terms from CMS:

The Part D deductible does not apply.
The $50 copay does not count toward TrOOP or the out-of-pocket maximum.
Part D plans don’t have to opt in.
A central processor handles prior authorization and claims.

That $50 sits below every cash price in this article. If you qualify, take it.

Medicare.gov lists the covered drugs: Foundayo (tablet), Wegovy (injection or tablet), and Zepbound (KwikPen only, not vials). Adults 18 and older qualify with:

BMI 35 or higher, or
BMI 30 to 34.9 plus a listed condition, or
BMI 27 to 29.9 plus a listed condition such as prediabetes or a prior heart attack or stroke.

People with type 2 diabetes, moderate-to-severe sleep apnea, or fatty liver disease are ineligible. A doctor submits the prescription and prior authorization.

One wrinkle: the CMS page snippet lists a narrower BMI 30 group (HFpEF or uncontrolled hypertension). The two sources differ, so check both and ask your prescriber which applies. Our guide to Bridge eligibility goes deeper. We also have no data on how often the Bridge is approved.

Commercially insured patients

Per the brief, people with commercial coverage for Wegovy can pay as little as $25 per month through Novo’s savings offer, capped at $100 per month in savings. Government-insured patients are excluded. If your plan covers Wegovy, call your insurer before you look at cash prices. A covered $25 fill beats $199 or $349 cash.

Cash buyers

With no coverage, you’re comparing programs. Roughly:

Lowest entry cost: the Wegovy pill’s starter doses, at $149 for 1.5 mg.
Predictable mid-range: Zepbound’s $299 and $399 tiers at the 2.5 mg and 5 mg doses.
Higher doses: Zepbound at $449 if you refill on time, versus the Wegovy pill at $299 or the pen at $349, depending on the dose you need.

Price is only part of the picture. Weigh how much weight loss each drug delivers, too.

What the trials say about efficacy

SURMOUNT-5 was an open-label head-to-head trial of 751 adults with obesity but without diabetes. Eli Lilly funded it. At week 72, the least-squares mean weight change was -20.2% on tirzepatide (Zepbound) and -13.7% on semaglutide (Wegovy). Tirzepatide was superior on both weight and waist circumference.

The Wegovy pen’s evidence comes from STEP 1: 1,961 adults without diabetes, randomized 2:1 to semaglutide 2.4 mg weekly or placebo for 68 weeks. Mean weight change was -14.9% with semaglutide versus -2.4% with placebo. Novo Nordisk funded it. Those results apply to the pen, not the pill.

Three caveats:

Both trials are industry-funded and excluded people with diabetes.
SURMOUNT-5 doesn’t cover the Wegovy pill.
Neither trial tells you which drug is the better value per dollar. More weight loss at one price doesn’t settle that question.

Our brief also lacks long-term outcome data. If you’re weighing cost against staying on therapy, read what happens after you stop in our piece on regain after stopping.

Where Lilly and the government fit in

Lilly announced an agreement with the U.S. government to expand access to obesity medicines. That agreement is the origin of the TrumpRx and Medicare pricing framework. We could not fetch its content, so we’re not stating its terms. Treat the link as a pointer.

A practical order of operations

Check Medicare eligibility first if you have Part D. A $50 copay is hard to beat.
Check commercial coverage if you’re privately insured. Ask about Wegovy coverage and the $25 savings offer.
Compare manufacturer cash programs if neither applies. Price the dose you’ll be on in month six, not just the starter dose.
Mind the clocks. Zepbound’s 45-day refill window and Wegovy’s intro-price end dates both change what you pay.
Re-verify before you buy. These prices move.

Frequently Asked Questions

What is TrumpRx and how do I use it for Wegovy or Zepbound?

Secondary sources describe TrumpRx as a government-branded portal that sends you to the manufacturers’ own cash programs, NovoCare and LillyDirect. It doesn’t sell drugs itself, and the price shown is usually the lowest dose. You still need a valid prescription. We couldn’t cite TrumpRx directly, so confirm details on the manufacturer pages, such as LillyDirect.

What does Zepbound cost with self-pay?

Lilly’s vial prices run $299 for 2.5 mg, $399 for 5 mg, and $449 for 7.5 to 15 mg when you refill within 45 days. Miss that window and the higher doses cost $599 to $1,049. The KwikPen is priced at the same low tiers; verify its higher-dose prices. Missing the 45-day refill window is the main way people overpay.

What does Wegovy cost with self-pay?

The pill is $149 for 1.5 mg and $299 for 9 mg and 25 mg. The 4 mg price needs verifying; sources say $199 or $299. The pen runs $199 for new patients at intro doses, then $349. The HD pen starts at $399. Intro windows have specific end dates, so check them.

Who saves more elsewhere?

Qualifying Medicare Part D enrollees pay $50 per month through the Bridge, which beats any cash price. Commercially insured people with Wegovy coverage can pay as little as $25 per month with the savings offer, capped at $100 per month in savings; government-insured people are excluded. Cash buyers can weigh the Wegovy pill’s low starter doses against Zepbound’s $299 and $399 tiers. SURMOUNT-5 favors tirzepatide for weight loss, but it says nothing about price.

Does the Novo list price cut in 2027 lower my cash price?

No. Novo says the January 1, 2027 list price cut to $675 doesn’t change direct-to-patient self-pay prices. It may help people with deductibles or coinsurance.

This article is for informational purposes only and is not medical advice. Talk to your healthcare provider before starting, stopping, or changing any medication.